Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331 Data on 2,451 men with metastatic seminoma ...
Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull Back Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results